Maria Klimentova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.

Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.

Journal: Transplantation and cellular therapy

Published: October 23, 2025

Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.

Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia/Lymphoma.

Journal: Transplantation and cellular therapy

Published: October 23, 2025

Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Baricitinib, Abatacept, Vedolizumab, and Reduced-Dose Post-Transplantation Cyclophosphamide in Pediatric Acute Leukemia: A Prospective Study.

Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Baricitinib, Abatacept, Vedolizumab, and Reduced-Dose Post-Transplantation Cyclophosphamide in Pediatric Acute Leukemia: A Prospective Study.

Journal: Transplantation and cellular therapy

Published: September 16, 2025

Calcineurin inhibitor-free GVHD prophylaxis with baricitinib, abatacept, vedolizumab, and reduced-dose PTCy in pediatric acute leukemia: a prospective study: PtCy, baricitinib, abatacept, and vedolizumab to prevent GVHD.

Calcineurin inhibitor-free GVHD prophylaxis with baricitinib, abatacept, vedolizumab, and reduced-dose PTCy in pediatric acute leukemia: a prospective study: PtCy, baricitinib, abatacept, and vedolizumab to prevent GVHD.

Journal: Transplantation and cellular therapy

Published: September 16, 2025

Long-term outcome of children with acute lymphoblastic leukemia after hematopoietic stem cell transplantation based on ex-vivo alpha-beta T cell depletion.

Long-term outcome of children with acute lymphoblastic leukemia after hematopoietic stem cell transplantation based on ex-vivo alpha-beta T cell depletion.

Journal: Annals of hematology

Published: August 14, 2025

Long-term outcomes of αβ T-cell/CD19 B-cell-depleted peripheral blood stem cell transplantation from unrelated donors in pediatric and adolescent patients with severe aplastic anemia: a single-center study.

Long-term outcomes of αβ T-cell/CD19 B-cell-depleted peripheral blood stem cell transplantation from unrelated donors in pediatric and adolescent patients with severe aplastic anemia: a single-center study.

Journal: Cytotherapy

Published: May 20, 2025

Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: results of a prospective trial.

Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: results of a prospective trial.

Journal: Bone marrow transplantation

Published: November 28, 2024

Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children.

Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children.

Journal: Transplantation and cellular therapy

Published: November 03, 2023

Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.

Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia.

Journal: Transplantation and cellular therapy

Published: July 14, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026